Cited by 196Reproductive Biology and FertilityDevelopmental Biology and Gene RegulationPI3K/AKT/mTOR signaling in cancer

Exogenous Amino Acids Regulate Trophectoderm Differentiation in the Mouse Blastocyst through an mTOR-Dependent Pathway

Open access
Martin, Patrick M., Sutherland, Ann E.·2001·Developmental Biology

Abstract

At the late blastocyst stage, the epithelial trophectoderm cells of the mammalian embryo undergo a phenotypic change that allows them to invade into the uterine stroma and make contact with the maternal circulation. This step can be regulated in vitro by the availability of amino acids. Embryos cultured in defined medium lacking amino acids cannot form trophoblast cell outgrowths on fibronectin, an in vitro model of implantation, but remain viable for up to 3 days in culture and will form outgrowths when transferred into complete medium. The amino acid requirement is a developmentally regulated permissive event that occurs during a 4- to 8-h period at the early blastocyst stage. Amino acids affect spreading competence specifically by regulating the onset of protrusive activity and not the onset of integrin activation. Rapamycin, a specific inhibitor of the kinase mTOR/FRAP/RAFT1, blocks amino acid stimulation of embryo outgrowth, demonstrating that mTOR is required for the initiation of trophectoderm protrusive activity. Inhibition of global protein translation with cycloheximide also inhibits amino acid-dependent signals, suggesting that mTOR regulates the translation of proteins required for trophoblast differentiation. Our data suggest that mTOR activity has a developmental regulatory function in trophectoderm differentiation that may serve to coordinate embryo and uterus at the time of implantation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1006/dbio.2001.0461

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment of mouse blastocysts with rapamycin or knockout of mTOR causes lethality at E5.5 associated with a failure of trophoblast outgrowth and maintenance of stem cells in the inner cell mass.

    “Indeed, treatment of mouse blastocysts with rapamycin or knockout of mTOR causes lethality at E5.5 associated with a failure of trophoblast outgrowth and maintenance of stem cells in the inner cell mass (206, 360).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [360]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 84 · Cited by 196

Authors
Martin, P. M., & Sutherland, A. E.
Affiliations
University of Virginia (US)
Corresponding author
Sutherland, Ann E.
Venue
Developmental Biology
Publisher
Elsevier BV
Published
2001-12
Volume
240
Issue
1
Pages
182-193
ISSN
0012-1606 (ISSN-L)
OpenAlex
W2005359040
Cited by
196
References
84
Citations by year
2026: 7 · 2025: 5 · 2024: 2 · 2023: 6 · 2022: 7 · 2021: 4 · 2020: 9 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 11 · 2015: 15 · 2014: 10 · 2013: 8 · 2012: 17
FWCI
4.26
Type
journal article
Language
en
Open access
Locations
  • Developmental Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD034807, 1RO1HD34807)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
trophectoderm differentiation, blastocyst, mTOR signaling, amino acids, trophoblast outgrowth, implantation, fibronectin, integrin activation, rapamycin, cycloheximide, mRNA translation, mouse embryo
MeSH terms
Amino Acids, Animals, Blastocyst, Cell Differentiation, Cell Movement, Ectoderm, Embryo, Mammalian, Female, Mice, Inbred ICR, Phosphorylation, Protein Kinases, Protein Biosynthesis, Trophoblasts, Signal Transduction, Ribosomal Protein S6 Kinases, Culture Techniques, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review